Wednesday, November 05, 2025 10:02:07 AM
Recent ARTL News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:18:10 PM
- Artelo Biosciences moves into glaucoma research with fully funded clinical study • IH Market News • 03/18/2026 03:00:51 PM
- Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study • GlobeNewswire Inc. • 03/18/2026 12:07:00 PM
- Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients • GlobeNewswire Inc. • 03/18/2026 11:41:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 08:45:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 01:30:28 PM
- Artelo Biosciences Announces Reverse Stock Split • GlobeNewswire Inc. • 03/06/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 01:01:07 PM
- Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:00:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 09:38:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 09:10:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 10:16:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/07/2026 09:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:17:04 PM
- Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate • GlobeNewswire Inc. • 12/23/2025 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/11/2025 09:14:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2025 09:05:26 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical • GlobeNewswire Inc. • 12/03/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:05:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2025 09:56:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:01:01 PM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
